Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 20;8(1):194-206.
doi: 10.1159/000541120. eCollection 2024 Jan-Dec.

eHealth and mHealth in Antimicrobial Stewardship Programs

Felipe Francisco Tuon  1 , Tiago Zequinao  1 , Marcelo Silva da Silva  1 , Kleber Oliveira Silva  1   2
Affiliations
Review

eHealth and mHealth in Antimicrobial Stewardship Programs

Felipe Francisco Tuon et al. Digit Biomark. .

Abstract

Background: The global need for rapid diagnostic methods for pathogen identification and antimicrobial susceptibility testing (AST) is underscored by the increasing bacterial resistance and limited therapeutic options, especially critical in sepsis management.

Summary: This review examines the aspects of the eHealth and mHealth in Antimicrobial Stewardship Programs (ASPs) to improve the treatment of infections and rational use of antimicrobials.

Key messages: The evolution from traditional phenotype-based methods to rapid molecular and mass spectrometry techniques has significantly decreased result turnaround times, improving patient outcomes. Despite advancements, the complex decision-making in antimicrobial therapy often exceeds the capacity of many clinicians, highlighting the importance of ASPs. These programs, integrating mHealth and eHealth, leverage technology to enhance healthcare services and patient outcomes, particularly in remote or resource-limited settings. However, the application of such technologies in antimicrobial management remains underexplored in hospitals. The development of platforms combining antimicrobial prescription data with pharmacotherapeutic algorithms and laboratory integration can significantly reduce costs and improve hospitalization times and mortality rates.

Keywords: Antimicrobial resistance; Antimicrobial stewardship; Pharmacotherapeutic algorithms; Rapid diagnostic methods; mHealth and eHealth.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.

Figures

Fig. 1.
Fig. 1.
Flow of clinical sample processing in the microbiology laboratory and approximate time for results. The arrows indicate potential test flows such as direct molecular examination of clinical samples or after growth on culture media. MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight; AST, antimicrobial susceptibility test; ID, identification.
Fig. 2.
Fig. 2.
Algorithm for developing a platform with retrospective clinical and microbiological data to generate appropriate empirical treatment, incorporating current patient clinical data and combining it with microbiological results for tele-stewardship application.
Fig. 3.
Fig. 3.
Screen of the tele-stewardship program used for pharmacotherapy interventions.
Fig. 4.
Fig. 4.
Impact of the approach type and its impacts on mortality, direct and indirect costs, and length of stay. The three approaches include the use of molecular tests in the initial stage of etiological diagnosis, using classic microbiology and a platform to assist in faster results and interaction with the care team, and the last is the approach of empirical use without intensive action from antimicrobial stewardship.
Fig. 5.
Fig. 5.
Potential impact of the MICLAB (tele-stewardship) integrating the laboratory (diagnostic stewardship).
Fig. 6.
Fig. 6.
Demonstrations of some impacts of tele-stewardship with rapid interaction in the laboratory on length of hospital stay, multiresistant bacteria (CRE, carbapenem-resistant enterobacteriales), cost with antimicrobial surgical prophylaxis, and antibiotic consumption.
Fig. 7.
Fig. 7.
Breakeven curve in a relationship between the cost of correctly administering empirical antibiotic therapy (blue line) compared to the cost of molecular testing on all clinical samples, including the costs of team and tele-stewardship software (red line).
See this image and copyright information in PMC

References

    1. Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. . Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–87. - PubMed
    1. Wenzler E, Maximos M, Asempa TE, Biehle L, Schuetz AN, Hirsch EB. Antimicrobial susceptibility testing: an updated primer for clinicians in the era of antimicrobial resistance: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2023;43(4):264–78. - PubMed
    1. Gao H, Liu Y, Wang R, Wang Q, Jin L, Wang H. The transferability and evolution of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae from clinical settings. EBioMedicine. 2020;51:102599. - PMC - PubMed
    1. Oteo J, Ortega A, Bartolome R, Bou G, Conejo C, Fernandez-Martinez M, et al. . Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem. Antimicrob Agents Chemother. 2015;59(6):3406–12. - PMC - PubMed
    1. Quiles MG, Rocchetti TT, Fehlberg LC, Kusano EJ, Chebabo A, Pereira RM, et al. . Unusual association of NDM-1 with KPC-2 and armA among Brazilian Enterobacteriaceae isolates. Braz J Med Biol Res. 2015;48(2):174–7. - PMC - PubMed

LinkOut - more resources